NewVue has closed on a round of seed funding to help launch its radiology workflow management platform, EmpowerSuite.
EmpowerSuite is a cloud-native platform that integrates AI and blends radiologist preferences, credentials, insurance details, and clinical priorities to update worklists, the company said. The user interface features a cockpit-style command center that includes an intelligent worklist and a Clinical Information Screen that provides a clinical data summary and timeline.
The software also features mood-adjusted tempo controls and personalized reading settings, which can simplify operations by eliminating complex rule configurations and manual worklist creation, the company said.
The undisclosed seed funding will enable NewVue.ai to innovate further, develop its proprietary technology, expand its talented team, and strengthen its position as a leader in the radiology solutions market, NewVue added.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
